Literature DB >> 26727654

Characterization of central nervous system multiple myeloma in the era of novel therapies.

Nazanin Majd1, Xiao Wei1, Alexis Demopoulos2,3, Adilia Hormigo2,3, Ajai Chari1,2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26727654     DOI： 10.3109/10428194.2015.1122786

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  7 in total

1.  Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence.

Authors:  Muhammad Bilal Abid; Sanjay De Mel; Muhammad Abbas Abid; Kong Bing Tan; Wee Joo Chng
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

2.  Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review.

Authors:  Rui Bergantim; Juliana Bastos; Maria José Soares; Bruno Carvalho; Pedro Soares; Cristina Marques; Jennifer Costa; José Eduardo Guimarães; Fernanda Trigo
Journal:  Case Rep Hematol       Date:  2020-01-03

Review 3.  Multiple Myeloma with Central Nervous System Relapse Early after Autologous Stem Cell Transplantation: A Case Report and Literature Review.

Authors:  Masaaki Hotta; Tomoki Ito; Akiko Konishi; Hideaki Yoshimura; Takahisa Nakanishi; Shinya Fujita; Atsushi Satake; Shosaku Nomura
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

4.  Secondary CNS myeloma with remission after systemic CNS-penetrating agents.

Authors:  Luis G Fernandez; Daniel Eduardo Oyon; Vinai Gondi; Sean Grimm; Osaama H Khan
Journal:  Neurooncol Adv       Date:  2022-07-01

Review 5.  Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance.

Authors:  Vincenzo Sammartano; Alfonso Cerase; Valentina Venanzi; Maria Antonietta Mazzei; Beatrice Esposito Vangone; Francesco Gentili; Ivano Chiarotti; Monica Bocchia; Alessandro Gozzetti
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

6.  A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone.

Authors:  Jew Win Kuan; Sing Ling Chai; Pathmanathan Rajadurai; Lee Gong Lau; Joseph Uchang; Sharifah Noor Akmal Syed Husain
Journal:  Case Rep Hematol       Date:  2022-08-31

Review 7.  Multiple myeloma with central nervous system relapse.

Authors:  Philip A Egan; Patrick T Elder; W Ian Deighan; Sheila J M O'Connor; H Denis Alexander
Journal:  Haematologica       Date:  2020-05-15       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.